LIVE MARKET TRACKER :   BSE SENSEX   26983.00      |    NSE NIFTY 8080.75    
GLOBAL MARKETS :  NASDAQ 4579.789   -0.30%    |    FSI London 6837.92   +0.27%    |    NIKKEI Japan 16196.93   -0.76%
  USD GBP EUR CAD AUD INR
USD - 0.6119 0.7774 1.0946 1.1228 60.7575
GBP 1.6346 - 1.2708 1.7892 1.8352 99.3136
EUR 1.2867 0.7873 - 1.4084 1.4446 78.1767
CAD 0.9136 0.559 0.7103 - 1.0258 55.5096
AUD 0.8908 0.5451 0.6925 0.9751 - 54.124
INR 0.0165 0.0101 0.0128 0.018 0.0185 -
Indian-Commodity  :  Corporate  :  Biocon enters into academic partnership with Trinity College of Dublin

Biocon enters into academic partnership with Trinity College of Dublin (27-Nov-2012)

Biocon has entered into academic partnership with Trinity College of Dublin. Indian students are to benefit from a new international scholarship fund that will support innovative genetics research taking place at Ireland's leading university, Trinity College Dublin, the University of Dublin, (www.tcd.ie).

Biocon, Asia's premier biotechnology company, has agreed to sponsor two annual scholarships to Trinity College Dublin that will give Indian students who demonstrate creativity, motivation and academic excellence the opportunity to travel to Ireland to work in top laboratories in Trinity College Dublin. The announcement was made during the largest-ever education mission to India, led by Minister for Training and Skills, Ciaran Cannon TD, organised by Enterprise Ireland.

Biocon is India's premier biotechnology company with a strategic focus on biopharmaceuticals and research services. Biocon produces anti-diabetic agents like Acarbose, Pioglitazone, Repaglinides and Rosiglitazone. In the biological segment it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), Streptokinase and Monoclonal Antibodies.


Top News Today
Four-member panel submits report on new gas pricing formula
(18-Sep-2014)

Four-member panel submits report on new gas pricing formulaA four-member panel of secretaries appointed by the government has submitted the much awaited report on a new gas pricing mechanism, which prescribes lower rate than the price approved by the previous......click on news to read complete article.

RIL, Sun Pharma and Apollo Tyres to see some action today
(18-Sep-2014)

RIL, Sun Pharma and Apollo Tyres to see some action todayIn a bid to grab the opportunity created by diesel reaching market-parity price, Reliance Industries (RIL) has set the ball rolling on reopening its fuel retail outlets, after a gap of six years, and the......click on news to read complete article.

Biocon, Lanco Infratech and Tata Steel to see some action today
(10-Sep-2014)

Biocon, Lanco Infratech and Tata Steel to see some action todayDrug maker Biocon has acquired GE Capital's entire 7.69 percent stake in its research services subsidiary Syngene International for Rs 215.38 crore. The company, which had sold the stake to GE on October......click on news to read complete article.

International Stock News
US markets closed mostly lower; Alibaba surges in IPO debut
(20-Sep-2014)

US markets closed mostly lower; Alibaba surges in IPO debutThe US markets closed mostly lower on Friday, while Alibaba, the biggest IPO to ever hit Wall Street, made a huge splash. Dallas Federal Reserve Bank President Richard Fisher stated that the Federal Reserve......click on news to read complete article.

US markets closed up; S&P, Dow at record highs
(19-Sep-2014)

US markets closed up; S&P, Dow at record highsThe US markets closed higher on Thursday, with the S&P 500 and Dow Jones Industrial Average closing at record levels, as investors welcomed the Federal Reserve's commitment to keep low interest......click on news to read complete article.

US markets closed up; Dow hits record high
(18-Sep-2014)

US markets closed up; Dow hits record highThe US markets closed higher on Wednesday, with the Dow Jones Industrial Average reaching a record high. The main benchmarks swung higher after the Fed meeting and Fed Chairwoman Janet Yellen's news conference,......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.